Variant report
Variant | nsv1057672 |
---|---|
Chromosome Location | chr20:15512342-15527164 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3071260 | chr20:15514213-15514214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs199648191 | chr20:15514214-15514215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527597312 | chr20:15514216-15514217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs71190189 | chr20:15514220-15514221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6110659 | chr20:15514265-15514266 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs553931937 | chr20:15514283-15514284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146712392 | chr20:15514318-15514319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545773720 | chr20:15514343-15514344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560222122 | chr20:15514407-15514408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs57465741 | chr20:15514425-15514426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114205992 | chr20:15514471-15514472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111332372 | chr20:15514520-15514521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73098278 | chr20:15514593-15514594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561510045 | chr20:15514626-15514627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534185865 | chr20:15514642-15514643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536758726 | chr20:15514649-15514650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529482221 | chr20:15514661-15514662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184660051 | chr20:15514701-15514702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547214696 | chr20:15514762-15514763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559784998 | chr20:15514782-15514783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533308251 | chr20:15514819-15514820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1233736 | chr20:15514821-15514822 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs189122684 | chr20:15514856-15514857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1233735 | chr20:15514898-15514899 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs535374234 | chr20:15514919-15514920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549715412 | chr20:15514949-15514950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551791903 | chr20:15514976-15514977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs149411927 | chr20:15514994-15514995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6079874 | chr20:15515065-15515066 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs1233734 | chr20:15515103-15515104 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs537495153 | chr20:15515120-15515121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs180713165 | chr20:15515126-15515127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145553867 | chr20:15515163-15515164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs117092194 | chr20:15515170-15515171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs186265482 | chr20:15515176-15515177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561625607 | chr20:15515187-15515188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189214514 | chr20:15515252-15515253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537966799 | chr20:15515300-15515301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs6110660 | chr20:15515392-15515393 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs536079696 | chr20:15515404-15515405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs1233733 | chr20:15515476-15515477 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs181586021 | chr20:15515478-15515479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs536497042 | chr20:15515514-15515515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs77422343 | chr20:15515523-15515524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554794456 | chr20:15515535-15515536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551593979 | chr20:15515536-15515537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs185810948 | chr20:15515547-15515548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs79987336 | chr20:15515567-15515568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549428454 | chr20:15515601-15515602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs74350682 | chr20:15515614-15515615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Glaucoma | 21310917 | CNVD |
Alagille syndrome | 22470819 | CNVD |
Lung cancer | 16773561 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Kabuki syndrome | 21720541 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Neurocytoma | 17123091 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
Multiple sclerosis | 20663923 | CNVD |
Schizophrenia | 20663923 | CNVD |
brain infarct | 20663923 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164920 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:15514200-15516000 | Enhancers | Fetal Brain Male | brain |
2 | chr20:15515200-15516000 | Enhancers | Brain Angular Gyrus | brain |
3 | chr20:15516600-15517200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr20:15516800-15517200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr20:15517200-15518600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr20:15518600-15520000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr20:15522400-15524800 | Weak transcription | Gastric | stomach |
8 | chr20:15524600-15524800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr20:15524600-15525400 | Enhancers | Placenta | Placenta |
10 | chr20:15525000-15526400 | Enhancers | Fetal Kidney | kidney |
11 | chr20:15525000-15526400 | Enhancers | Ovary | ovary |
12 | chr20:15525200-15526200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr20:15525200-15526600 | Enhancers | Fetal Heart | heart |
14 | chr20:15525400-15526200 | Enhancers | Brain Germinal Matrix | brain |
15 | chr20:15525400-15526600 | Enhancers | Fetal Stomach | stomach |
16 | chr20:15525600-15526000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr20:15525600-15526000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
18 | chr20:15525600-15526600 | Enhancers | Fetal Lung | lung |
19 | chr20:15526000-15526800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
20 | chr20:15526600-15528000 | Weak transcription | Fetal Lung | lung |